Texas InstrumentsTPS73233MDBVREPLinear Regulators

LDO Regulator Pos 3.3V 0.25A 5-Pin SOT-23 T/R

Use the LDO TPS73233MDBVREP linear regulator from Texas Instruments to maintain a constant output voltage. This device has a maximum power dissipation of 638 mW. It has an overall accuracy of ±0.5 %. Its typical dropout voltage at current is 0.04@250mA V. This voltage regulation device's single output can produce a current up to 0.25 A. Supply your circuit with sufficient power by implementing this, which requires a minimum input voltage of 1.7 V that does not exceed 5.5 V. With a fixed output that has a voltage of 3.3 V, this is power management at its best. At a load regulation of 0.002%/mA(Typ) and line regulation of 0.01%/V(Typ) your circuit is capable of maintaining a constant voltage level at your output. Its maximum power dissipation is 638 mW. In order to ensure safe delivery and enable quick mounting of this component after delivery, it will be encased in tape and reel packaging during shipment. This voltage regulation device has a minimum operating temperature of -55 °C and a maximum of 125 °C. Its polarity is positive. The maximum dropout voltage is 0.15@250mA V.

2,581 parts: Ships in 2 days

    Total$2.45Price for 1

    • Service Fee  $7.00

      Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2318+
      Manufacturer Lead Time:
      18 weeks
      Minimum Of :
      1
      Maximum Of:
      2581
      Country Of origin:
      Thailand
         
      • Price: $2.453
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2318+
      Manufacturer Lead Time:
      18 weeks
      Country Of origin:
      Thailand
      • In Stock: 2,581 parts
      • Price: $2.453

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.